Exascale Labs Holdings Statistics
Total Valuation
XLAB has a market cap or net worth of $267.22 million. The enterprise value is $266.23 million.
| Market Cap | 267.22M |
| Enterprise Value | 266.23M |
Important Dates
The last earnings date was Thursday, September 10, 2026.
| Earnings Date | Sep 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XLAB has 91.20 million shares outstanding.
| Current Share Class | 60.46M |
| Shares Outstanding | 91.20M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.40 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.28
| Current Ratio | 0.28 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 16.26% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $1.31M |
| Profits Per Employee | -$939,811 |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.43% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -70.43% |
| 50-Day Moving Average | 5.99 |
| 200-Day Moving Average | 9.21 |
| Relative Strength Index (RSI) | 30.39 |
| Average Volume (20 Days) | 415,566 |
Short Selling Information
The latest short interest is 518,598, so 0.57% of the outstanding shares have been sold short.
| Short Interest | 518,598 |
| Short Previous Month | n/a |
| Short % of Shares Out | 0.57% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.17 |
Income Statement
In the last 12 months, XLAB had revenue of $13.10 million and -$9.40 million in losses.
| Revenue | 13.10M |
| Gross Profit | 2.12M |
| Operating Income | -3.40M |
| Pretax Income | -9.40M |
| Net Income | -9.40M |
| EBITDA | -3.39M |
| EBIT | -3.40M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $984,830 in cash and no debt, with a net cash position of $984,830 or $0.01 per share.
| Cash & Cash Equivalents | 984,830 |
| Total Debt | n/a |
| Net Cash | 984,830 |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | -20.91M |
| Book Value Per Share | n/a |
| Working Capital | -21.02M |
Cash Flow
| Operating Cash Flow | -4.01M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 6,795 |
| Net Borrowing | n/a |
| Free Cash Flow | -4.01M |
| FCF Per Share | -$0.04 |
Margins
Gross margin is 16.14%, with operating and profit margins of -25.96% and -71.74%.
| Gross Margin | 16.14% |
| Operating Margin | -25.96% |
| Pretax Margin | -71.74% |
| Profit Margin | -71.74% |
| EBITDA Margin | -25.91% |
| EBIT Margin | -25.96% |
| FCF Margin | n/a |
Dividends & Yields
XLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.52% |
| FCF Yield | -1.50% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
XLAB has an Altman Z-Score of -0.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.35 |
| Piotroski F-Score | 2 |